Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94


Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study.

Griffin JT, Bhatt S, Sinka ME, Gething PW, Lynch M, Patouillard E, Shutes E, Newman RD, Alonso P, Cibulskis RE, Ghani AC.

Lancet Infect Dis. 2016 Apr;16(4):465-72. doi: 10.1016/S1473-3099(15)00423-5. Epub 2016 Jan 20.


China-Africa cooperation initiatives in malaria control and elimination.

Xia ZG, Wang RB, Wang DQ, Feng J, Zheng Q, Deng CS, Abdulla S, Guan YY, Ding W, Yao JW, Qian YJ, Bosman A, Newman RD, Ernest T, O'leary M, Xiao N.

Adv Parasitol. 2014;86:319-37. doi: 10.1016/B978-0-12-800869-0.00012-3. Review.


Malaria vaccine technology roadmap.

Moorthy VS, Newman RD, Okwo-Bele JM.

Lancet. 2013 Nov 23;382(9906):1700-1. doi: 10.1016/S0140-6736(13)62238-2. Epub 2013 Nov 14. No abstract available.


Mosquito larval source management: evaluating evidence in the context of practice and policy.

Newman RD, Mnzava A, Szilagyi Z.

Cochrane Database Syst Rev. 2013 Aug 29;(8):ED000066. doi: 10.1002/14651858.ED000066. No abstract available.


Assessment of the RTS,S/AS01 malaria vaccine.

Moorthy VS, Newman RD, Duclos P, Okwo-Bele JM, Smith PG.

Lancet Infect Dis. 2013 Apr;13(4):280-2. doi: 10.1016/S1473-3099(13)70047-1. Epub 2013 Mar 1. No abstract available.


WHO and the future of disease control programmes.

Dye C, Mertens T, Hirnschall G, Mpanju-Shumbusho W, Newman RD, Raviglione MC, Savioli L, Nakatani H.

Lancet. 2013 Feb 2;381(9864):413-8. doi: 10.1016/S0140-6736(12)61812-1.


Progress towards malaria control targets in relation to national malaria programme funding.

Korenromp EL, Hosseini M, Newman RD, Cibulskis RE.

Malar J. 2013 Jan 14;12:18. doi: 10.1186/1475-2875-12-18.


Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

Moorthy VS, Hutubessy R, Newman RD, Hombach J.

Bull World Health Organ. 2012 Nov 1;90(11):864-6. doi: 10.2471/BLT.12.107482. Epub 2012 Sep 19. No abstract available.


Artemisinin-resistant malaria in the Asia-Pacific region.

Tulloch J, David B, Newman RD, Meek S.

Lancet. 2013 Jun 1;381(9881):e16-7. doi: 10.1016/S0140-6736(12)61820-0. Epub 2012 Oct 31. No abstract available.


Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.

Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel EM, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD, Menard D.

PLoS One. 2012;7(10):e45797. doi: 10.1371/journal.pone.0045797. Epub 2012 Oct 1.


Comment on: Promotion of malaria home-based treatment in Africa: the dangers of creating a second health system.

Pagnoni F, Reeder JC, Newman RD.

Int Health. 2012 Jun;4(2):151-2. doi: 10.1016/j.inhe.2012.03.006. No abstract available.


Relegating malaria resurgences to history.

Newman RD.

Malar J. 2012 Apr 24;11:123. doi: 10.1186/1475-2875-11-123.


Strengthening the policy setting process for global malaria control and elimination.

D'Souza BJ, Newman RD.

Malar J. 2012 Jan 27;11:28. doi: 10.1186/1475-2875-11-28.


The threat of artemisinin-resistant malaria.

Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV.

N Engl J Med. 2011 Sep 22;365(12):1073-5. doi: 10.1056/NEJMp1108322. No abstract available.


Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi.

Thigpen MC, Filler SJ, Kazembe PN, Parise ME, Macheso A, Campbell CH, Newman RD, Steketee RW, Hamel M.

Am J Trop Med Hyg. 2011 Mar;84(3):379-85. doi: 10.4269/ajtmh.2011.10-0186.


Learning to outwit malaria.

Newman RD.

Bull World Health Organ. 2011 Jan 1;89(1):10-1. doi: 10.2471/BLT.11.040111. No abstract available.


A research agenda for malaria eradication: health systems and operational research.

malERA Consultative Group on Health Systems and Operational Research.

PLoS Med. 2011 Jan 25;8(1):e1000397. doi: 10.1371/journal.pmed.1000397. Review.


A research agenda for malaria eradication: diagnoses and diagnostics.

malERA Consultative Group on Diagnoses and Diagnostics.

PLoS Med. 2011 Jan 25;8(1):e1000396. doi: 10.1371/journal.pmed.1000396. Review.


A research agenda for malaria eradication: drugs.

malERA Consultative Group on Drugs.

PLoS Med. 2011 Jan 25;8(1):e1000402. doi: 10.1371/journal.pmed.1000402. Review.


A research agenda to underpin malaria eradication.

Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman RD, Plowe CV, Rodríguez MH, Sinden R, Slutsker L, Tanner M.

PLoS Med. 2011 Jan 25;8(1):e1000406. doi: 10.1371/journal.pmed.1000406. Review.

Supplemental Content

Loading ...
Support Center